Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03478462
Title Dose Escalation Study of CLR 131 in Children and Adolescents With Relapsed or Refractory Malignant Brain Cancer, Neuroblastoma, Rhabdomyosarcoma, Ewings Sarcoma, and Osteosarcoma
Acronym CLOVER-2
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Cellectar Biosciences, Inc.
Indications
Therapies
Age Groups: adult | child
Covered Countries USA | CAN | AUS

Facility Status City State Zip Country Details
Lucile Packard Children's Hospital Palo Alto California 94304 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10065 United States Details
Duke University Chapel Hill North Carolina 27708 United States Details
Cincinnati Children's Hospital Medical Center Cincinnati Ohio 45229 United States Details
Texas Children's Hospital Houston Texas 77030 United States Details
University of Wisconsin Hospital and Clinics Madison Wisconsin 53792 United States Details
Children's Hospital at Westmead Westmead New South Wales 2145 Australia Details
Hospital for Sick Children Toronto Ontario M5G1X8 Canada Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field